Modular Bioprocessing System for CAR T Cell Manufacturing

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Existing bioprocessing systems for manufacturing CAR T cells are complex, costly, inflexible, and prone to workflow bottlenecks due to high human touchpoints, which increases the risk of contamination and reduces manufacturing efficiency.

Innovation Solution

A bioprocessing system with modular design, including a centrifugal processing chamber, heating/cooling mixing chamber, and magnetic isolation module, utilizing disposable kits and automated processes to streamline cell isolation, activation, genetic modification, and expansion, allowing for parallel processing of multiple samples and reducing human intervention.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Reliability

If traditional manual bioprocessing systems are used for CAR T cell manufacturing, then flexibility and adaptability are maintained, but contamination risk increases and manufacturing efficiency decreases due to high human touchpoints

Engineering Contradiction:
Improvecontamination riskVSAvoidhuman touchpoints
Core Design Contradiction:
ReliabilityVSExtent of automation

Solution Approach 1:

The bioprocessing system is divided into separate functional modules (centrifugal processing chamber, heating/cooling mixing chamber, magnetic isolation module) that can operate independently. This segmentation allows automated closed-system processing while maintaining process flexibility, reducing human intervention points without sacrificing adaptability.

Inventive Principle:
Principle #1Segmentation

Solution Approach 2:

The patent introduces automated robotic systems and closed-loop fluid handling as intermediaries between operators and the bioprocessing equipment. These intermediaries enable programmatic control of manufacturing steps, eliminating direct human contact with cell products while maintaining process controllability and flexibility through software interfaces.

Inventive Principle:
Principle #24Intermediary (Mediator)

2Reliability

If complex automated bioprocessing systems are implemented, then contamination risk is reduced, but system cost and complexity increase

Engineering Contradiction:
Improvecontamination riskVSAvoidsystem complexity
Core Design Contradiction:
ReliabilityVSDevice complexity

Solution Approach 1:

The bioprocessing system employs multi-functional modules that can perform multiple operations. For example, the centrifugal processing chamber handles both cell separation and concentration, while the magnetic isolation module performs both cell capture and washing functions. This multi-functionality reduces the total number of separate components needed, lowering overall system complexity while maintaining automated contamination control.

Inventive Principle:
Principle #6Universality (Multi-functionality)

Solution Approach 2:

The system utilizes disposable single-use bioprocessing bags and cartridges that are discarded after a single use, eliminating the need for complex sterilization and cleaning systems. This approach reduces infrastructure complexity while maintaining closed-system automation that prevents contamination, as each disposable component is pre-sterilized and designed for single-use automated processing.

Inventive Principle:
Principle #34Discarding and recovering

3Productivity

If manual processing steps are used for cell expansion, then system cost is reduced, but manufacturing efficiency and productivity decrease

Engineering Contradiction:
Improvemanufacturing efficiencyVSAvoidautomated processing
Core Design Contradiction:
ProductivityVSExtent of automation

Solution Approach 1:

The bioprocessing system implements continuous automated processing where cell cultures are continuously monitored and manipulated without manual intervention. The automated system maintains continuous agitation, feeding, and environmental control during cell expansion, eliminating idle time between manual operations and maximizing productive cell growth time while keeping operational costs manageable through efficient resource utilization.

Inventive Principle:
Principle #20Continuity of useful action

4Adaptability or versatility

If existing automated systems are used, then human intervention is reduced, but flexibility and adaptability are lost due to equipment-specific workflow requirements

Engineering Contradiction:
Improveprocess flexibilityVSAvoidequipment specialization
Core Design Contradiction:
Adaptability or versatilityVSDevice complexity

Solution Approach 1:

The system employs dynamic, reconfigurable automation where processing parameters, protocols, and even physical configurations can be changed through software control without requiring dedicated equipment for each process variant. The modular design with standardized interfaces allows automated adaptation to different cell types, scales, and processing requirements, maintaining flexibility while reducing the need for specialized equipment for each application.

Inventive Principle:
Principle #15Dynamics

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

The system enhances manufacturing efficiency, reduces contamination risks, and improves flexibility by automating key processes, enabling simultaneous expansion of multiple cell therapies while maintaining regulatory compliance and patient safety.

Implementation Method 1

a centrifugal processing chamber, configured to receive a blood product and separate cells from the blood product

Methodology Applied
Scientific EffectCentrifugal separation: Centrifugal Separation

Implementation Method 2

a magnetic isolation module, configured to isolate the activated T cells from the cell population

Methodology Applied
Scientific EffectMagnetic separation: Magnetic Field

Data Source

PatentUS20230416666A1Culture vessel for a bioprocessing system
Publication Date: 2023.12.28 GLOBAL LIFE SCIENCES SOLUTIONS USA LLC
  • US20230416666A1 patent drawing
  • US20230416666A1 patent drawing
  • US20230416666A1 patent drawing

AI summary

A bioreactor vessel includes a base having a plurality of through openings, a lid connected to the base via a plurality of heat stakes, and a gas-permeable, liquid impermeable membrane sandwiched between the base and the lid and held in position by the plurality heat stakes.